Celldex Therapeutics Inc. (CLDX) at a glance

Celldex Therapeutics Inc. (CLDX) is a mid-cap Healthcare company. It trades at $36.9, with a 0% profit margin and revenue decline of 97.8%. It does not pay a dividend. Vestovix scores it 43/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Growth (11/100). Its volatility is roughly in line with the market.

Price

$36.90

Market cap

$2.45B

P/E ratio

n/a

Dividend yield

None

Beta

0.93

52-week range

$21.71 to $45.14